Results 261 to 270 of about 91,122 (346)
Heat shock protein 10 as a chaperone modulating α‐synuclein amyloid fibril formation
Abstract HSP10 is a well‐known human co‐chaperone that interacts with HSP60 to comprise the HSP60/10 chaperonin complex which upholds mitochondrial proteostasis. HSP10 also demonstrates independent roles in binding to misfolded proteins and interacts with several amyloidogenic client proteins.
Johan N. K. Larsson +5 more
wiley +1 more source
Association of Terazosin, Doxazosin, or Alfuzosin Use and Risk of Dementia With Lewy Bodies in Men [PDF]
Alexander Hart +4 more
openalex +1 more source
Does Platelet Transcriptome Dysregulation Across the Lewy Body Continuum Mirror Neuronal Dysfunction? [PDF]
Arnaldo L +12 more
europepmc +1 more source
Abstract The misfolding and aggregation of α‐synuclein is a central molecular event in the etiology of Parkinson's disease and related disorders. α‐synuclein misfolding and pathology are both concentration‐dependent, but it is not clear precisely how changes in concentration alter the folding landscape within cells. Whereas most conventional structural
Daeun Noh, Robert W. Newberry
wiley +1 more source
FloodUnet: A Rapid Spatio‐Temporal Prediction Model for Flood Evolution Based on an Enhanced U‐Net
Abstract Flooding causes significant loss of life and economic damage and affects healthy development of society. Deep learning (DL) models demonstrate significant advantages in improving computational efficiency while maintaining accuracy. Existing research of predicting dynamic flood evolution still remains some gaps for predicting flooding maps from
T. Chen +6 more
wiley +1 more source
Identification of expanded and interrupted ATXN2 repeat expansions in Parkinson's disease and Lewy Body Dementia cohorts. [PDF]
Wang L +5 more
europepmc +1 more source
Salivary Extracellular vesicles (SEVs) isolated from PD patients exhibit increased levels of both total (α‐SynTot) and oligomeric alpha‐synuclein (α‐SynOlig). In PD patients, SEVS‐α‐SynOlig levels correlate with cognitive decline (MMSE) and motor fluctuations (MDS‐UPDRS IV) and remain stable after 1 year follow‐up.
Antonia Gurgone +9 more
wiley +1 more source

